arrow
A

Andrew Menzies-Gow

respiratory and immunology
H指数:64
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of Easier Biologic Access with Remission and Other Clinical Outcomes in Severe Asthma: A Global Real-World Study

易得生物制剂与重症哮喘缓解及其他临床结局的关联:一项全球真实世界研究

2026-08-060
OA
Early and Sustained Asthma Control and Remission in Real-World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC-2

早期并持续的哮喘控制与缓解:使用Benralizumab治疗的真实世界重度嗜酸性粒细胞哮喘患者研究——XALOC-2

2025-10-290
OAAI
Severe asthma is characterized by a sex-specific ILC landscape and aberrant airway profile that is suppressed by anti-IL-5/5Rα biologics

重症哮喘的特征是具有性别特异性的ILC景观和被抗IL-5/5Rα生物制剂抑制的异常气道表型。

2025-10-011
PRE
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approach

对重度哮喘患者T2炎症程度梯度下生物制剂应答的研究:一种数据驱动的生物标志物聚类方法

2025-09-020
OAAI
Impact of Biologics Initiation on Oral Corticosteroid Use in the International Severe Asthma Registry and the Optimum Patient Care Research Database: A Pooled Analysis of Real-World Data

生物制剂启动对口服糖皮质激素使用的影响:国际重症哮喘注册登记研究与国际患者护理研究数据库的真实世界数据合并分析

2025-04-260
OAAI
Impact of biologic initiation on oral corticosteroids in the International Severe Asthma Registry and the Optimum Patient Care Research Database: a pooled analysis
2024-10-300
PRE
Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults

成人重症哮喘生物治疗后临床缓解的定义和预测因素探讨

2024-10-018
OAAI
Exploring Definitions and Predictors of Response to Biologics for Severe Asthma
2024-09-018
OAAI
Real-world biologics response and super-response in the International Severe Asthma Registry cohort

国际重症哮喘登记队列中的真实世界生物制剂反应和超反应

2024-06-220
OAAI
EFFECT OF BENRALIZUMAB VERSUS MEPOLIZUMAB ON REDUCTION IN ORAL GLUCOCORTICOID USE IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS

苯那利珠单抗与美泊利珠单抗对嗜酸性肉芽肿性多血管炎患者口服糖皮质激素使用减少的影响

2024-06-011
PRE
Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma

重症哮喘患者的前生物T2-biomarker组合与对生物制剂的反应之间的关联

2024-04-196
OAAI